Adenosine-2-carboxy methyl amide

Adenosine-2-carboxy methyl amide is a purine nucleoside analog demonstrating broad anti-tumor activity in indolent lymphoid malignancies. Its mechanisms involve inhibiting DNA synthesis and inducing apoptosis, as shown in relevant in vitro and in vivo research models for hematological cancers.